Therapeutic potential of snake venom in cancer therapy: Current perspectives

Asian Pacific Journal of Tropical Biomedicine

Volumn 3, Issue 2, 2013, Pages 156-162

  Vyas, Vivek Kumar ^a   Brahmbhatt, Keyur ^a   Bhatt, Hardik ^a   Parmar, Utsav ^b  

^a NIRMA UNIVERSITY   (India)

^b Arihant School of Pharmacy and Bioresearch Institute   (India)

Author keywords

Anticancer agents; Apoptosis inducer; Cytotoxin; Snake venom

Indexed keywords

ACETYLCHOLINESTERASE; ACTX 6; ACTX 8; AMINO ACID OXIDASE; ARGINASE; COLLAGENASE; DEOXYRIBONUCLEASE; HYALURONIDASE; HYDROLASE; LACTATE DEHYDROGENASE; NUCLEOTIDASE; PHOSPHODIESTERASE; PHOSPHOLIPASE; PROTEIN BCL XL; PROTEINASE; RIBONUCLEASE; SNAKE VENOM; THROMBIN; THROMBIN LIKE ENZYME; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER THERAPY; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTINUOUS INFUSION; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG ISOLATION; DRUG PROTEIN BINDING; DRUG SCREENING; GLIOMA; HUMAN; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN HYDROLYSIS; STOMACH CARCINOMA; TOXIN ANALYSIS; CELL MOTION; DRUG EFFECTS; NEOPLASMS;

ANTINEOPLASTIC AGENTS; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; NEOPLASMS; SNAKE VENOMS;

EID: 84873023302     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(13)60042-8     Document Type: Article

References (54)

1. Leon G, Sanchez L, Hernandez A, Villalta M, Herrera M, Segura A, et al. Immune response towards snake venoms. Inflamm Allergy Drug Targets 2011, 10:381-398.
2. Marsh N, Williams V Practical applications of snake venom toxins in haemostasis. Toxicon 2005, 45:1171-1181.
3. Daltry JC, Wuster W, Thorpe RS Diet and snake venom evolution. Nature 1996, 379:537-540.
4. Sanchez EF, Schneider FS, Yarleque A, Borges MH, Richardson M, Figueiredo SG, et al. The novel metalloproteinase atroxlysin-I from Peruvian Bothrops atrox (Jergón) snake venom acts both on blood vessel ECM and platelets. Arch Biochem Biophy 2010, 496:9-20.
5. Tashima AK, Sanz L, Camargo ACM, Serrano SMT, Calvete JJ Snake venomics of the Brazilian pitvipers, Bothrops cotiara and Bothrops fonsecai, Identification of taxonomy markers. J Proteo 2008, 71:473-485.
6. Guan HH, Goh KS, Davamani F, Wu PL, Huang YW, Jeyakanthan J, et al. Structures of two elapid snake venom metalloproteases with distinct activities highlight the disulfide patterns in the D domain of ADA Malysin family proteins. J Stru Biol 2010, 169:294-303.
7. Jin H, Varner J Integrins: roles in cancer development and as treatment targets. Br J Cancer 2004, 90:561-565.
8. Yamazaki Y, Morita T Snake venom components affecting blood coagulation and the vascular system: structural similarities and marked diversity. Cur Pharma Des 2007, 13:2872-2886.
9. Debatin KM, Krammerr P Death receptors in chemotherapy and cancer. Oncogene 2004, 23:2950-2966.
10. Park MH, Choi MS, Kwak DH, Oh KW, Yoon DY, Han SB, et al. Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB. EINSTEIN 2011, 71:801-812.
11. Tang N, Xie Q, Wang X, Li X, Chen Y, Lin X, et al. Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and epithelial-mesenchymal transition. Arch Pharm Res 2011, 34:781-789.
12. Park MH, Jo M, Won D, Song HS, Song MJ, Hong JT Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins. Apoptosis 2012, 17:1316-1326.
13. Heinen TE, da Veiga ABG Arthropod venoms and cancer. Toxicon 2011, 57:497-511.
14. Kalam Y, Isbister GK, Mirtschin P, Hodgson WC, Konstantakopoulos N Validation of a cell-based assay to differentiate between the cytotoxic effects of elapid snake venoms. J Pharmacol Toxicol Methods 2011, 63:137-142.
15. Gomes A, Bhattacharjee P, Mishra R, Biswas AK, Dasgupta SC, Giri B Anticancer potential of animal venoms and toxins. Indian J Exp Biol 2010, 48:93-103.
16. Santos MMDV, Santana CD, Giglio JR, Da Silva RJ, Sampaio SV, Soares AM, et al. Antitumoural effect of an L-amino acid oxidase isolated from Bothrops jararaca snake venom. Basic Clin Phramacol Toxicol 2008, 102:533-542.
17. Kitchens CS, Eskin TA Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome. J Med Toxicol 2008, 4:180-183.
18. Biardi JE, Chien DC, Coss RG California ground squirrel (Spermophilus beecheyi) defenses against rattlesnake venom digestive and hemostatic toxins. J Chem Ecol 2006, 32:137-154.
19. Antunes TC, Yamashita KM, Barbaro KC, Saiki M, Marcelo L Santoro Comparative analysis of newborn and adult Bothrops jararaca snake venoms. Toxicon 2010, 56:1443-1458.
20. Sales PBV, Santoro ML Nucleotidase and DNase activities in Brazilian snake venoms. Compr Biochem Physiol 2008, 147C:85-95.
21. Chu CW, Tsai TS, Tsai IH, Lin YS, Tu MC Prey envenomation does not improve digestive performance in Taiwanese pit vipers (Trimeresurus gracilis and T. stejnegeri stejnegeri). Compr Biochem Physiol 2009, 152A:579-585.
22. Wuster W, Peppin L, Pook CE, Walker DE A nesting of vipers: phylogeny, historical biogeography and patterns of diversification of the Viperidae (Squamata: Serpentes). Mol Phylogenet Evol 2008, 49:445-459.
23. Tsai CH, Yang SH, Chien CM, Lu MC, Lo CS, Lin YH, et al. Mechanisms of cardiotoxin III-induced apoptosis in human colorectal cancer colo205 cells. Clin Exp Pharmacol Physiol 2006, 33:177-182.
24. Gallacci M, Cavalcante WLG Understanding the in vitro neuromuscular activity of snake venom Lys49 phospholipase A2 homologues. Toxicon 2010, 55:1-11.
25. Marcussi S, Sant'Ana CD, Oliveira CZ, Rueda AQ, Menaldo DL, Beleboni RO, et al. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential. Cur Topics Med Chem 2007, 7:743-756.
26. Gutierrez JM, Alexandra R, Escalante T, Díaz C Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 2005, 45:997-1011.
27. Marshall DM Enzyme activities and biological functions of snake venoms. Appl Herpetol 2005, 2:109-123.
28. Aguilar I, Guerrero B, Salazar AM, Giron ME, Perez JC, Sanchez EE, et al. Individual venom variability in the South American rattlesnake Crotalus durissus cumanensis. Toxicon 2007, 50:214-224.
29. Gutierrez JM, Ownby CL Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity. Toxicon 2003, 42:915-931.
30. Yamazaki Y, Takani K, Atoda H, Morita T Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J Biol Chem 2003, 278:51985-51988.
31. Chippaux JP, Williams V, White J Snake venom variability: methods of study, results and interpretation. Toxicon 1991, 29:1279-1303.
32. Warrell DA Snake venoms in science and clinical medicine. Russell's viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg 1989, 83:732-740.
33. Shashidharamurthy R, Jagadeesha DK, Girish KS, Kemparaju K Variation in biochemical and pharmacological properties of Indian cobra (Naja naja) venom due to geographical distribution. Mol Cell Biochem 2002, 229:93-101.
34. You WK, Choi WS, Koh YS, Shin HC, Jang Y, Chung KH Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris. FEBS Letters 2004, 571:67-73.
35. Mackessy SP Biochemistry and pharmacology of colubrid snake venoms. J Toxicol Toxin Rev 2002, 21:43-83.
36. Jin H, Varner J Integrins: roles in cancer development and as treatment targets. Br J Cancer 2004, 90:561-565.
37. Koh CY, Kini RM From snake venom toxins to therapeutics - Cardiovascular examples. Toxicon 2012, 59:497-506.
38. Zhang L, Wei LJ ACTX-8, a cytotoxic L-amino acid oxidase isolated from Agkistrodon acutus snake venom, induces apoptosis in Hela cervical cancer cells. Life Sci 2007, 80:1189-1197.
39. Torii S, Yamane K, Mashima T, Haga N, Yamamoto K, Fox JW, et al. Molecular cloning and functional analysis of apoxin I, a snake venom-derived apoptosis-inducing factor with L-amino acid oxidase activity. Biochemistry 2000, 39:3197-3205.
40. Naumann GB, Silva LF, Silva L, Faria G, Richardson M, Evangelista K Cytotoxicity and inhibition of platelet aggregation caused by an L-amino acid oxidase from Bothrops leucurus venom. Biochim Biophys Acta 2011, 1810:683-694.
41. Ahn MY, Lee BM, Kim YS Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah). Int J Biochem Cell Biol 1997, 29:911-919.
42. Gebrim LC, Marcussi S, Menaldo DL, De Menezes CSR, Nomizo A, Hamaguchi A Antitumor effects of snake venom chemically modified Lys49 phospholipase A2-like BthTX-I and a synthetic peptide derived from its C-terminal region. Biologicals 2009, 37:222-229.
43. Guo MP, Wang QC, Liu GF Pharmacokinetics of cytotoxin from chinese cobra (Naja naja atra) venom. Toxicon 1993, 31:339-343.
44. Debnath A, Saha A, Gomes A, Biswas S, Chakrabarti P, Giri B, et al. A lethal cardiotoxic-cytotoxic protein from the Indian monocellate cobra (Naja kaouthia) venom. Toxicon 2010, 56:569-579.
45. Das T, Bhattacharya S, Halder B, Biswas A, Gupta SD, Gomes A Cytotoxic and antioxidant property of a purified fraction (NN-32) of Indian Naja naja venom on Ehrlich ascites carcinoma in BALB/c mice. Toxicon 2011, 57:1065-1072.
46. De Carvalho DD, Schmitmeier S, Novello JC, Markland FS Effect of BJcuL (a lectin from the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and endothelial cells. Toxicon 2001, 39:1471-1476.
47. Zhang L, Cui L A cytotoxin isolated from Agkistrodon acutus snake venom induces apoptosis via Fas pathway in A549 cells. Toxicol In Vitro 2007, 21:1095-1103.
48. Sun LK, Yoshii Y, Hyodo A, Tsurushima H, Saito A, Harakuni T, et al. Apoptotic effect in the glioma cells induced by specific protein extracted from Okinawa habu (Trimeresurus flavoviridis) venom in relation to oxidative stress. Toxicol In Vitro 2003, 17:169-177.
49. Karthikeyan R, Karthigayan S, Sri Balasubashini M, Somasundaram ST, Balasubramanian T Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom. Toxicon 2008, 51:157-161.
50. Yang RS, Tang CH, Chuang WJ, Huang TH, Peng HC, Huang TF, et al. Inhibition of tumor formation by snake venom disintegrin. Toxicon 2005, 45:661-669.
51. Gomes A, Choudhury SR, Saha A, Mishra R, Giri B, Biswas AK, et al. A heat stable protein toxin (drCT-I) from the Indian viper (Daboia russelli russelli) venom having antiproliferative, cytotoxic and apoptotic activities. Toxicon 2007, 49:46-56.
52. Lin KL, Su JC, Chien CM, Chuang PW, Chang LS, Lin SR Down-regulation of the JAK2/PI3K-mediated signaling activation is involved in Taiwan cobra cardiotoxin III-induced apoptosis of human breast MDA-MB-231 cancer cells. Toxicon 2010, 55:1263-1273.
53. Nunes ES, Souza MA, Vaz AF, Silva TG, Aguiar JS, Batista AM Cytotoxic effect and apoptosis induction by Bothrops leucurus venom lectin on tumor cell lines. Toxicon 2012, 59:667-671.
54. Nolte S, De Castro DD, Barea AC, Gomes J, Magalhães A, Mello Zischler LF A lectin purified from Bothrops jararacussu venom, induces apoptosis in human gastric carcinoma cells accompanied by inhibition of cell adhesion and actin cytoskeleton disassembly. Toxicon 2012, 59:81-85.